Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 55Neoplasms, Plasma Cell 22Central Nervous System Neoplasms 10Prostatic Neoplasms 9Glioblastoma 9Recurrence 8Melanoma 8Brain Neoplasms 8Neoplasms 7Gliosarcoma 7Carcinoma, Non-Small-Cell Lung 7Sarcoma 6Leukemia 6Carcinoma, Hepatocellular 6Waldenstrom Macroglobulinemia 5Myeloproliferative Disorders 5Lung Neoplasms 5Leukemia, Lymphocytic, Chronic, B-Cell 5Glioma 5Colorectal Neoplasms 5Myelodysplastic-Myeloproliferative Diseases 4Myelodysplastic Syndromes 4Lymphoma 4Liver Neoplasms 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Kidney Neoplasms 4Carcinoma, Renal Cell 4Lymphoma, Mantle-Cell 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Chronic 3

Interventions

fludarabine phosphate 8Cyclophosphamide 7Peripheral Blood Stem Cell Transplantation 6Mycophenolic Acid 6Whole-Body Irradiation 5Cyclosporine 5Tacrolimus 4Methotrexate 4Alemtuzumab 4Rituximab 3thymoglobulin 2fludarabine 2Transplantation 2Radiotherapy 2Melphalan 2Epoetin Alfa 2Cyclosporins 2Busulfan 2Antilymphocyte Serum 2tipifarnib 1ruxolitinib 1nelarabine 1merphos 1blinatumomab 1aldesleukin 1Thiotepa 1Therapeutics 1Thalidomide 1Sunitinib 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Large Granular Lymphocytic × Thalidomide × Clear all
NCT06530576 2025-11-18

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Recruiting
48 enrolled
Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡